Fundamentals

Valuation

Metric	Q4	Q2	Δ in %
EV/EBITDA	100.00	18.82	0.00
Graham Fair Price	100.00	0.22	0.00
PEG	-100.00	-0.31	0.00
Price/Book	-100.00	-31.91	0.00
Price/Cash Flow	100.00	699.79	0.00
Prices/Earnings	100.00	10.04	0.00
Price/Sales	100.00	3.72	0.00
Price/FCF	100.00	699.79	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q2	Δ in %
Gross Profit Margin	100.00	0.52	0.00
Operating Margin	100.00	0.17	0.00
ROA	n.A.	0.05	n.A.
ROE	n.A.	-0.79	n.A.
ROIC	n.A.	0.13	n.A.
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q2	Δ in %
Debt QOQ	< 0.005	-0.24	98.52
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	-0.20	-100.00
EPS QOQ	0.00	-0.32	-100.00
FCF QOQ	0.00	-0.98	-100.00
Revenue QOQ	0.00	-0.14	-100.00
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	11.13	100.00
Days Sales Outstanding (DSO)	0.00	1.10	100.00
Inventory Turnover	n.A.	8.09	n.A.
Debt/Capitalization	1.22	1.11	-8.46
Quick Ratio	0.26	0.25	-4.18
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q2	Δ in %
Book Value	0.00	-0.05	-100.00
Cash	0.00	0.07	100.00
Capex	0.00	-0.02	-100.00
Free Cash Flow	0.00	< 0.005	100.00
Revenue	0.00	0.44	100.00
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q2	Δ in %
Current Ratio	0.36	0.39	6.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.00	4.29	100.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating